Home | Welcome to Contract Pharma   
Last Updated Saturday, October 25 2014

Search Results for 'Phase III'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »

Contract Service Directory Categories

View All Categories »

Search Results:

Published October 3, 2014
Tabalumab fails to meet efficacy expectations Read More »
By Kristin Brooks
Published January 30, 2014
To provide imaging services for multi-site oncology trial Read More »
By Kristin Brooks
Published January 23, 2014
Reduces LDL-C in statin intolerant patients Read More »
By Kristin Brooks
Published January 23, 2014
Demonstrates statistically significant benefit Read More »
Published November 26, 2013
Meets primary endpoint in cUTI Read More »
By Gil Roth
Published November 5, 2013
End-of-Phase II meeting with FDA goes well Read More »
Published October 24, 2013
To investigate safety and effectiveness in breast cancer with BRCA1 or BRCA2 gene mutations Read More »
By Gil Roth
Published September 30, 2013
Metastatic melanoma treatment posts positive Phase II results Read More »
Published February 27, 2012
Following Phase II testing, a drug is tested in a large-scale setting (several hundred to several thousand patients) to determine effectiveness, benefits, and the range of possible adverse reactions. Most Phase III studies are randomized and double b… Read More »
By Asif Alidina, SVP Commercial Operations - North Americas
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On